Divalproex Sodium 125 mg Enteric-Coated Tablet

Divalproex Sodium 125 mg Enteric-Coated Tablet is a enteric-coated tablet formulated with 125 mg. The active ingredient profile is Divalproex Sodium, placing the product in the anticonvulsant / mood-stabilizing agent category. Divalproex Sodium is an anticonvulsant and mood-stabilizing medicine with indication and monitoring requirements that depend on the approved product label. The enteric coating is intended to delay tablet disintegration until after passage through the stomach, subject to the approved finished-product specification. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and the prescriber’s judgement. Prescription status, precautions, interactions, adverse effects and dosing must be checked against the current approved product label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.